These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17506919)

  • 21. Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease.
    Imöhl M; Reinert RR; Ocklenburg C; van der Linden M
    J Clin Microbiol; 2010 Apr; 48(4):1291-6. PubMed ID: 20107087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in serotype prevalence and antimicrobial resistance among invasive Streptococcus pneumoniae isolates in Korea, 1996-2008.
    Lee S; Bae S; Lee KJ; Yu JY; Kang Y
    J Med Microbiol; 2013 Aug; 62(Pt 8):1204-1210. PubMed ID: 23657529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.
    Singh J; Sundaresan S; Manoharan A; Shet A
    Vaccine; 2017 Aug; 35(35 Pt B):4501-4509. PubMed ID: 28711387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991-1998.
    Huebner RE ; Wasas AD; Klugman KP
    Int J Infect Dis; 2000; 4(4):214-8. PubMed ID: 11231185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children.
    Zissis NP; Syriopoulou V; Kafetzis D; Daikos GL; Tsilimingaki A; Galanakis E; Tsangaropoulou I
    Eur J Pediatr; 2004 Jul; 163(7):364-8. PubMed ID: 15118910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics.
    Jetté LP; Delage G; Ringuette L; Allard R; De Wals P; Lamothe F; Loo V;
    J Clin Microbiol; 2001 Feb; 39(2):733-7. PubMed ID: 11158138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of pneumococcal serotypes and conjugate vaccine formulations.
    Butler JC
    Microb Drug Resist; 1997; 3(2):125-9. PubMed ID: 9185138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.
    Hofmann J; Cetron MS; Farley MM; Baughman WS; Facklam RR; Elliott JA; Deaver KA; Breiman RF
    N Engl J Med; 1995 Aug; 333(8):481-6. PubMed ID: 7623880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.
    Fenoll A; Granizo JJ; Aguilar L; Giménez MJ; Aragoneses-Fenoll L; Hanquet G; Casal J; Tarragó D
    J Clin Microbiol; 2009 Apr; 47(4):1012-20. PubMed ID: 19225097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009.
    Srifeungfung S; Tribuddharat C; Comerungsee S; Chatsuwan T; Treerauthanaweeraphong V; Rungnobhakhun P; Nunthapisud P; Chokephaibulkit K
    Vaccine; 2010 Apr; 28(19):3440-4. PubMed ID: 20199759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cross-sectional survey of the prevalence of Streptococcus pneumoniae nasopharyngeal carriage in Belgian infants attending day care centres.
    Malfroot A; Verhaegen J; Dubru JM; Van Kerschaver E; Leyman S
    Clin Microbiol Infect; 2004 Sep; 10(9):797-803. PubMed ID: 15355410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment.
    Stephens DS; Zughaier SM; Whitney CG; Baughman WS; Barker L; Gay K; Jackson D; Orenstein WA; Arnold K; Schuchat A; Farley MM;
    Lancet; 2005 Mar 5-11; 365(9462):855-63. PubMed ID: 15752529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002-2003.
    Chen YY; Yao SM; Chou CY; Chang YC; Shen PW; Huang CT; Su HP; Li SY
    J Med Microbiol; 2006 Aug; 55(Pt 8):1109-1114. PubMed ID: 16849732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotype distribution and antimicrobial resistance patterns of nasopharyngeal and invasive Streptococcus pneumoniae isolates in Hong Kong children.
    Ho PL; Lam KF; Chow FK; Lau YL; Wong SS; Cheng SL; Chiu SS
    Vaccine; 2004 Sep; 22(25-26):3334-9. PubMed ID: 15308357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
    Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.